Akari Therapeutics (AKTX) Shareholder's Equity (QoQ) (2015 - 2026)
Akari Therapeutics (AKTX) Shareholder's Equity (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.24% |
| Dec 31, 2025 | 24.86% |
| Sep 30, 2025 | -11.40% |
| Jun 30, 2025 | 17.75% |
| Mar 31, 2025 | -2.17% |
| Dec 31, 2024 | 432.07% |
| Sep 30, 2024 | -80.77% |
| Jun 30, 2024 | -4.22% |
| Mar 31, 2024 | -1,451.53% |
| Dec 31, 2023 | -207.51% |
| Sep 30, 2023 | -92.34% |
| Jun 30, 2023 | -57.61% |
| Mar 31, 2023 | 266.33% |
| Dec 31, 2020 | 35.06% |
| Sep 30, 2020 | 16.63% |
| Jun 30, 2020 | 82.26% |
| Mar 31, 2020 | 42,919.07% |
| Dec 31, 2019 | -99.85% |
| Sep 30, 2019 | 967.20% |
| Jun 30, 2019 | -90.51% |